Table 2: The genes that significantly differed between survivors and deceased patients; A. Biological function of the genes with significantly higher expression in the tumours from deceased patients compared to the tumours from 10-year survivors.

Additional file 3 Van't Veer's genes in our material. Gene symbol and accession number for the genes in van't Veer's gene list found in our data.

Additional file 4 Wang's genes in our material. Gene symbol and accession number for the genes in Wang's gene list found in our data.

Supplemental Table 1.  Pathways and associated genes analyzed in the study.

Table 4: Expression of cell cycle genes in breast cancers.

Supplemental Table 1. Differential Gene Expression in JDbetabetaHE-infected EB cells compared to Mock-infected EB cells.

Table 1. Differentially expressed genes of interest; no significant changes were observed in the expression of genes known to be involved in apoptosis  interferon or DNA damage responses  or nuclear factor  B (NF kappa B)-related pathways

Supplemental Table 2. Differential Gene Expression in JDbetabeta-Pax3-infected EB cells compared to Mock-infected EB cells.

Supplementary Table 1 A total of 773 genes exhibited at least a two-fold change in expression levels between CL1-5/CLDN1 and CL1-5/vector control are listed

Supplementary Table 2. The genes in the 5 significant pathways which have more genes differentially expressed among the phenotype classes than expected by chance (sorted by p-values)

Supplementary Table 1. The genes in the significant GO categories which have more genes differentially expressed among the phenotype classes than expected by chance consist of the following genes (sorted by p-values)

Table 1. Gene regulation in peripheral blood mononuclear cells (PBMCs) from normal donors after 1 h IFN-a treatment in vitro; Genes had a probe set differentially expressed by >2-fold (P < 0.001)

Table 3. Comparison of gene expression profiles after in vitro and in vivo treatment of patient PBMCs with IFN-a-2b